Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Acusensus Ltd ( (AU:ACE) ) has shared an update.
Acusensus Ltd has applied for quotation of 240,164 ordinary fully paid shares on the ASX under its existing ticker ACE. The new securities, issued on 4 March 2026 under an employee incentive scheme, will be quoted and freely transferable, modestly increasing the company’s free float and aligning staff interests with shareholders.
The move reflects Acusensus’s ongoing use of equity-based remuneration to incentivise employees within the constraints of ASX Listing Rules. While the issuance is relatively small, it incrementally broadens the company’s capital base and may support liquidity in trading of ACE shares over time.
The most recent analyst rating on (AU:ACE) stock is a Buy with a A$2.30 price target. To see the full list of analyst forecasts on Acusensus Ltd stock, see the AU:ACE Stock Forecast page.
More about Acusensus Ltd
Acusensus Ltd is listed on the Australian Securities Exchange under the code ACE. The company operates in the technology sector, with its ordinary fully paid shares traded on the ASX and subject to standard listing and quotation rules.
Average Trading Volume: 163,629
Technical Sentiment Signal: Buy
Current Market Cap: A$289.8M
Find detailed analytics on ACE stock on TipRanks’ Stock Analysis page.

